Matrix stiffness regulates profibrotic fibroblast differentiation and fibrotic niche activation in systemic sclerosis
Annals of the Rheumatic Diseases · 2025
DOI: 10.1016/j.ard.2025.05.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2025. Verfasst von Ludwig Ueberall und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine 3 -Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, …. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Fibroblasts, Extracellular Matrix, Cell Differentiation. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Friedrich-Alexander-Universität Erlangen-Nürnberg, Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg.
Abstract (Originalsprache)
OBJECTIVES: Fibrosis progression in systemic sclerosis (SSc) has been attributed to matrix stiffness. Despite extensive research on fibroblast heterogeneity and subset imbalances in fibrotic disorders, the interplay between biomechanical cues and fibroblast dynamics remains largely unexplored. Here, we investigate how matrix stiffness alters fibroblast transcriptional state and influences lineage specification in fibrotic skin. METHODS: We employed a collagen I-based 3-dimensional culture system to expose fibroblasts to varying levels of matrix stiffness, followed by RNA sequencing to identify stiffness-responsive gene expression signature. We integrated single-cell RNA sequencing data from SSc and healthy skin samples to identify fibroblast subsets associated with this signature. Spatial transcriptomic analyses were performed to localise these fibroblasts and their associations with the fibrotic niche. RESULTS: Fibroblasts subjected to increased matrix stiffness exhibited a distinct transcriptional signature, amplified in SSc patients and enriched in PI16+ progenitor-like cells within the SFRP2+ fibrotic compartment. Further analysis indicated that PI16+ fibroblasts are predisposed to SFRP2+COMP+ PU.1+ myofibroblasts differentiation, whereas blocking mechanotransduction by focal adhesion kinase inhibition disrupts this process, suggesting that matrix stiffness is a key driver of this lineage transition. Spatial mapping revealed colocalisation of the PI16+ and COMP+ subsets in extracellular matrix-dense regions, highlighting the functional relevance of this relationship in fibrotic progression. CONCLUSIONS: Our findings suggest that increased matrix stiffness promotes fibroblast precursor differentiation into SFRP2+ COMP+ PU.1+ myofibroblasts, thereby sustaining the vicious cycle of persistent fibrosis in absence of inflammatory triggers. These insights reveal new aspects of fibrosis pathogenesis and highlight biomechanical signals as therapeutic targets in SSc.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Internal Medicine 3 -Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany; Deutsches Zentrum für Immuntherapie (DZI), Friedric…
- Optical Imaging Competence Centre (OICE), Friedrich-Alexander-Universität Erlangen-Nuremberg, Erlangen, Germany.
- Department of Rheumatology, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University; Düsseldorf, Germany.
- Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Förderung
- European Research Council
- Friedrich-Alexander-Universität Erlangen-Nürnberg
- Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg
- Innovative Medicines Initiative
- European Commission
- BMBF Bonn
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Ueberall, L., Mohammadian, H., Demmler, R., Ariza, Y., Tripal, P., Anchang, C. G., Weber, S., Angeli, M. R., Raimondo, M. G., Chang, J., Huang, K., Distler, J. H. W., Distler, O., Rauber, S., Schett, G., Ramming, A., & Ramming, A. M. (2025). Matrix stiffness regulates profibrotic fibroblast differentiation and fibrotic niche activation in systemic sclerosis. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2025.05.016
Vancouver
Ueberall L, Mohammadian H, Demmler R, Ariza Y, Tripal P, Anchang CG, et al. Matrix stiffness regulates profibrotic fibroblast differentiation and fibrotic niche activation in systemic sclerosis. Annals of the Rheumatic Diseases. 2025. doi:10.1016/j.ard.2025.05.016
BibTeX
@article{Ueberall2025,
author = {Ueberall, Ludwig and Mohammadian, Hashem and Demmler, Richard and Ariza, Yuko and Tripal, Philipp and Anchang, Charles Gwellem and Weber, Stefanie and Angeli, Mario Raphael and Raimondo, Maria Gabriella and Chang, Jiyang and Huang, Kaiyue and Distler, Jörg H W and Distler, Oliver and Rauber, Simon and Schett, Georg and Ramming, Andreas and Ramming, Alina Mihaela},
title = {Matrix stiffness regulates profibrotic fibroblast differentiation and fibrotic niche activation in systemic sclerosis},
journal = {Annals of the Rheumatic Diseases},
year = {2025},
doi = {10.1016/j.ard.2025.05.016}
}
EUVIMED